<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-one unselected patients with refractory <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001903'>anemias</z:hpo> of various etiologies were treated with <z:chebi fb="1" ids="4315">danazol</z:chebi>, a synthetic attenuated <z:chebi fb="3" ids="50113">androgen</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had previously failed treatment with hematinics, <z:chebi fb="5" ids="50113">androgens</z:chebi>, <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, high-dose intravenous immunoglobulin, antithymocyte globulin, cytotoxic <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi>, and/or plasmapheresis </plain></SENT>
<SENT sid="2" pm="."><plain>Three patients with pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> and one with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> responded </plain></SENT>
<SENT sid="3" pm="."><plain>No responses were observed in 11 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, two patients with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, and two with <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Remission in pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> was maintained with <z:chebi fb="1" ids="4315">danazol</z:chebi> alone in one patient and required combined low-dose <z:chebi fb="0" ids="8382">prednisone</z:chebi> in two </plain></SENT>
<SENT sid="5" pm="."><plain>Objective responses occurred in 2 to 3 weeks and therapy generally was well tolerated </plain></SENT>
<SENT sid="6" pm="."><plain>To date, one patient with pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> remains in complete remission at 9 months on low-dose <z:chebi fb="1" ids="4315">danazol</z:chebi> alone </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that <z:chebi fb="1" ids="4315">danazol</z:chebi> alone or combined with <z:chebi fb="0" ids="8382">prednisone</z:chebi> may induce and maintain remission in severe refractory pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> and possibly other <z:hpo ids='HP_0011010'>chronic</z:hpo> cytopenias characterized by immunologic marrow suppression </plain></SENT>
<SENT sid="8" pm="."><plain>Further trials of <z:chebi fb="1" ids="4315">danazol</z:chebi> in treating these disorders are indicated </plain></SENT>
</text></document>